Patents by Inventor Reza Ziai

Reza Ziai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
    Patent number: 6433144
    Abstract: This invention relates to methods for isolating highly purified mixtures of natural Type I interferon from white blood cells. The invention also relates to highly-purified mixtures of Type I interferon which resemble natural Type I interferon in that the highly purified mixtures of natural Type I interferon includes at least 9 subtypes, i.e., alpha-1, alpha-2, alpha-5, alpha-7, alpha-8, alpha-10, alpha-14, alpha-21 and omega, giving rise to at least 16, and possibly 20 or more molecular species, including alpha-1a, alpha-1new, alpha-2a, alpha-2b, alpha-2c, alpha-5, alpha-5LG, alpha-7, alpha-8a, alpha-8c, alpha-10a, alpha-14a, alphal4-b, alpha 14-c, alpha-14LG, alpha-21a, alpha-21b, alpha-21c, omega and omega LG.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: August 13, 2002
    Assignee: Viragen, Inc.
    Inventors: Joseph P. Morris, Duy Nguyen, James Kappelman, Michael D. Potter, Mead M. McCabe, Reza Ziai, Stephen Feldman, Hipolito Hartman
  • Compositions of highly-purified natural mixtures of type I interferon derived from leukocytes and methods
    Patent number: 6350589
    Abstract: This invention relates to methods for isolating highly-purified mixtures of natural type I interferons from white blood cells. The invention also relates to highly-purified mixtures of natural type I interferons which resemble natural type I interferon in that it includes 9 subtypes, i.e., alpha-1, alpha-2, alpha-5, alpha-7, alpha-8, alpha-10, alpha-14, alpha-21 and omega, giving rise to possibly 20 molecular species, including alpha-1a, alpha-1new, alpha-2a, alpha-2b, alpha-2c, alpha-5, alpha-5LG, alpha-7, alpha-8a, alpha-8c, alpha-10a, alpha-14a, alpha14-b, alpha 14-c, alpha-14LG, alpha-21a, alpha-21b, alpha-21c, omega and omega LG.
    Type: Grant
    Filed: December 31, 1998
    Date of Patent: February 26, 2002
    Assignee: Viragen, Inc.
    Inventors: Joseph P. Morris, Duy Nguyen, James Kappelman, Michael D. Potter, Mead M. McCabe, Reza Ziai, Stephen B. Feldman, Hipolito Hartman
  • Binding assay utilizing a nucleic acid encoding apamin binding protein
    Patent number: 5652111
    Abstract: The present invention relates to an isolated nucleic acid fragment comprising a nucleic acid sequence encoding an apamin receptor protein, or biologically active fragment thereof.
    Type: Grant
    Filed: May 8, 1995
    Date of Patent: July 29, 1997
    Assignee: American Cyanamid Company
    Inventors: Patricia Tyson Sokol, Mohammad Reza Ziai